Skip to main content
. 2014 May 15;7(5):1435–1441.

Table 1.

Clinical features and biomarkers according to body mass index and presence or absence of T2DM

Control n = 36 Obese n = 11 BMI < 40 Obese n = 20 BMI > 40 Obese without DM n = 31 Obese with DM n = 9
Age (years) 38 ± 11 41.5 ± 15 40.7 ± 10.4 40.7 ± 11 41.75 ± 15.27
Gender F/M 18/18 7/4 19/1 25/6 8/1
BMI kg/m2 24 ± 4 33.75 ± 3.1 48.3 ± 7.5 43 ± 9.3 45.9 ± 9.5
SBP mmHg 111 ± 9 115.8 ± 9 122.9 ± 10.5 120.3 ± 10.3 122.5 ± 11.6
DBP mmHg 70 ± 6 77.9 ± 7.8 80 ± 5.5 79.38 ± 6 80 ± 7.56
Glucose mg/dL 89 ± 13 98.85 ± 8.7 93.8 ± 4.5 96.3 ± 3.7 114 ± 27.4*
HOMA-IR 2 ± 1.05 3.49 ± 3.1 5.4 ± 3.2 4.67 ± 3 6.1 ± 4.05**
HbA1c (%) 4.2 ± 1.4 4.3 ± 2.7 5.96 ± 0.4 5.57 ± 2.3 5.98 ± 3.4
TC mg/dL 167 ± 8 192 ± 30.86 191.4 ± 30.7 189.2 ± 30.2 200 ± 31.3
HDL-C mg/dL 49 ± 7 38.5 ± 6.2 42.1 ± 10 41 ± 8.4 42.3 ± 13.5
LDL-C mg/dL 95 ± 7 115.4 ± 17.8 118.2 ± 22.8 116.1 ± 21.2 123.2 ± 23.5
Triglycerides mg/dL 120 ± 8 248.7 ± 105.4 178.1 ± 72 202.8 ± 91.4 168 ± 55.3
AST median (range) IU/L 19 (12-26) 20 (17-40) 21 (14-128) 21 (14-128) 22 (14-25)
ALT median (range) IU/L 20 (16-31) 30.5 (19-91) 21 (13-189) 25 (13-189) 23 (14-38)
GGT median (range) IU/L 21.5 (15-35) 29.5 (15-104) 28 (15-177) 28 (15-177) 38 (17-159)
Uric acid mg/dL 3.5 ± 1.1 5.3 ± 1.9 6.4 ± 1.3 6.34 ± 1.7 7 ± 2.3
Creatinine clearance ml/min/1.73 m2 96.9 ± 29 100.5 ± 66 139.5 ± 47.9 129.8 ± 54.3 122 ± 43.8
Leptin ng/mL 3.6 ± 1.8 5.3 ± 3.02 6.3 ± 4 6.2 ± 4 5.3 ± 2.6
Resistin ng/mL 5.4 ± 2.2 8.7 ± 1.6 8.87 ± 2.3 8.66 ± 2.06 9.4 ± 2.5
IL-2 pg/mL < 5 38.5± 13.1 48.1 ± 11.8 39.6± 18.9 81 ± 12.3**
IL-6 pg/mL 7.4 ± 8.3 177.2 ± 117.4 213.3 ± 80.76 197.5 ± 78.97 223.6 ± 115
IL-10 pg/mL < 5 11.5 ± 8.5 25.39 ± 7.4 19.65 ± 6 36 ± 19
TNFα pg/mL 10 ± 4 63.5 ± 13.5** 8.24 ± 4.5 19.18 ± 14.8 14 ± 12
Ghrelin pg/mL 1465 ± 12 1780 ± 197** 1149 ± 89.03 1351 ± 116.9 987.4 ± 114*

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transaminase, DM, diabetes mellitus.

*

p < 0.01 (obese without DM vs. obese with DM).

**

p < 0.05 with respect to all groups (ANOVA, post-hoc Tukey).